Skip to main navigation

    Library: Global (English)  Life Sciences - 26
    Next >>

    Title  

    Date 

    Location 

    Description

    The new revenue recognition standard — for life sciences companies filing under US GAAP
    (pdf, 135.50 KB)
    17 Dec, 2014 Global

    The new revenue standard could result in significant changes in practice for life sciences entities.

    EY - The new revenue recognition standard - for life sciences companies reporting under IFRS - November 2014 The new revenue recognition standard - for life sciences companies reporting under IFRS - November 2014
    (pdf, 225.82 KB)
    17 Dec, 2014 Global

    Life sciences entities will have to changesome aspects of their revenue recognition practices.

    EY - Nordic Life Sciences sector study 2014 Nordic Life Sciences sector study 2014
    (pdf, 8.63 MB)
    08 Dec, 2014 Global

    The Nordic Life Sciences sector is, despite a relatively small combined population of ca 25 million inhabitants.

    EY - The new revenue recognition standard - life sciences The new revenue recognition standard - life sciences
    (pdf, 218.17 KB)
    04 Dec, 2014 Global

    Life sciences entities may need to change certain revenue recognition practices as a result of the introduction of the new revenue standard.

    EY - MedTech Europe MedTech Europe
    (pdf, 679.28 KB)
    26 Nov, 2014 Global

    MORE NEEDS.HIGHER EXPECTATIONS.SMALLER BUDGETS.Can the European MedTech Industry Deliver?

    AdvaMed 2014: hot topics
    (pdf, 145.33 KB)
    04 Nov, 2014 Global

    Commoditization is real, and differentiation is an imperative

    EY - Worldwide-randd-incentives-reference-guide Worldwide R&D incentives reference guide 2014-2015
    (pdf, 8.33 MB)
    31 Oct, 2014 Global

    Our latest guide offers a description of available benefits, the incentive application process, eligibility and IP jurisdictional requirements. Learn about the latest R&D incentives.

    EY -  IN VIVO IN VIVO
    (pdf, 906.27 KB)
    31 Oct, 2014 Global

    EY's Jeff Greene and Andrew Forman comment on deal activity in INVIVO's September 2014 issue "M&A tops 2009 merger mania"

    To the Point
    (pdf, 85.87 KB)
    30 Oct, 2014 Global

    Learn how final regulations issued by the IRS will change the way pharma manufacturers account for the annual branded prescription drug fee.

    Technical Line - Aug - 2014
    (pdf, 130.59 KB)
    26 Sep, 2014 Global

    The new revenue recognition standard - life sciences

    Next >>
    Back to top